InMed Pharmaceuticals (INM) Change in Acquisitions & Divestments (2019 - 2026)

InMed Pharmaceuticals has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $16511.0 in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 2.96% year-over-year to $16511.0 in Q1 2026; TTM through Mar 2026 was $43898.0, a 10.83% increase from a year earlier, with the FY2025 full-year figure at $42270.0, changed 0.45% from the prior year.
• Change in Acquisitions & Divestments was $16511.0 for Q1 2026 at InMed Pharmaceuticals, up from $4199.0 in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $21324.0 in Q3 2024, with the low at -$431.0 in Q2 2024.
• Average Change in Acquisitions & Divestments over 4 years is $12601.9, with a median of $16274.0 recorded in 2025.
• The largest YoY upside for Change in Acquisitions & Divestments was 617.63% in 2025 against a maximum downside of 24.34% in 2025.
• Over 4 years, Change in Acquisitions & Divestments stood at $21317.0 in 2023, then slumped by 87.44% to $2678.0 in 2024, then surged by 56.8% to $4199.0 in 2025, then surged by 293.21% to $16511.0 in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $16511.0 (Q1 2026), $4199.0 (Q4 2025), and $20957.0 (Q3 2025), per Business Quant data.